(Q48532439)

English

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

author name string

Ramon Sanchez

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Christopher Williams

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Jose L Daza

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Qinghong Dan

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Qingcheng Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Yijun Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Christina Delgado

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Neary Arpajirakul

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Edward W B Jeffes

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Ronald C Kim

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Thomas Douglass

11

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Usama Al Atar

12

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

H Terry Wepsic

13

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Martin R Jadus

14

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Cellular Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

215

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

1-11

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

A comparison of treatment results for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Induction of interferon-gamma inducing factor in the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Interferon-alpha and -gamma expression in the rat testis

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracrani

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Cytotoxic properties of CD4(+) T-cell clones which lyse HLA class II negative autologous non-small-cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

The prospects for cancer gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Identifiers

10.1016/S0008-8749(02)00011-4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48532439&oldid=1372762968"